-
ADDRESSING IMMATURE OVERALL SURVIVAL DATA IN ONCOLOGY COST-EFFECTIVENESS MODELING: A TRIANGULATED FRAMEWORK FOR ROBUST EXTRAPOLATION
Aug 11, 2026, 17:16 PM -
ANALYSIS OF TRANSPARENCY COMMISSION EVALUATIONS OF ADOLESCENT INDICATION EXTENSIONS IN RELATION TO CORRESPONDING ADULT EVALUATIONS IN FRANCE
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFECTIVENESS OF EHEALTH INTERVENTIONS ON QUALITY OF LIFE AND PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH LUNG CANCER: A NETWORK META-ANALYSIS
Aug 11, 2026, 17:16 PM -
HOW WILL MEMBER STATES USE IT? NATIONAL UPTAKE AND THE "DUE CONSIDERATION" OF JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
FROM MEDICAL WRITER TO MEDICAL EDITOR: REDEFINING THE ROLE OF HTA PROFESSIONALS IN THE AGE OF AI-ASSISTED DOCUMENT DEVELOPMENT
Aug 11, 2026, 17:16 PM -
REAL-WORLD ADHERENCE TO RIBOCICLIB-BASED THERAPY IN HR+/HER2- ADVANCED BREAST CANCER: A RETROSPECTIVE COHORT STUDY IN ROMANIA
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF ADDING INTERMITTENT PNEUMATIC COMPRESSION TO PHARMACOLOGICAL THROMBOPROPHYLAXIS AFTER TOTAL HIP AND KNEE ARTHROPLASTY: A FRENCH HEALTH-SYSTEM ANALYSIS
Aug 11, 2026, 17:16 PM -
TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
SURVIVAL OUTCOMES OF ABIRATERONE AND ENZALUTAMIDE IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: A SINGLE-CENTER RETROSPECTIVE ANALYSIS
Aug 11, 2026, 17:16 PM -
TREATMENT EFFECT WANING ASSUMPTIONS VERSUS LONG-TERM EVIDENCE FOR IMMUNE CHECKPOINT INHIBITORS IN NICE'S SINGLE TECHNOLOGY APPRAISALS
Aug 11, 2026, 17:16 PM -
AN 8-POINT WORSENING AND A 10-POINT IMPROVEMENT ON THE MULTIPLE-SCLEROSIS IMPACT SCALE 29-ITEM (MSIS-29) V2 ARE CLINICALLY MEANINGFUL
Aug 11, 2026, 17:16 PM -
INFREQUENT AND LIMITED TO LITERATURE REVIEWS: AI USE IN NICE HTA SUBMISSIONS IN ONCOLOGY
Aug 11, 2026, 17:16 PM -
MAPPING THE LANDSCAPE OF CLINICAL GOVERNANCE MEASUREMENT: A GLOBAL SCOPING REVIEW OF INSTRUMENTS, APPLICATIONS, AND OUTCOMES
Aug 11, 2026, 17:16 PM -
VALUE ASSESSMENT OF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS IN CHINA: A RAPID HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:16 PM -
A COST-CALCULATOR MODEL TO ESTIMATE THE ECONOMIC IMPACT OF OBINUTUZUMAB FOR THE TREATMENT OF LUPUS NEPHRITIS IN ITALY
Aug 11, 2026, 17:16 PM -
CLOSING THE GAP: QUANTIFYING MFN PRICING EXPOSURE AND STRATEGIC RESPONSES IN MEDICARE
Aug 11, 2026, 17:16 PM -
PULSE OXIMETRY MEASUREMENT ERROR, OCCULT HYPOXEMIA, AND ORGAN DYSFUNCTION ACROSS RACIAL AND ETHNIC GROUPS IN CRITICALLY ILL ADULTS IN UNITED STATES
Aug 11, 2026, 17:16 PM -
QUANTIFYING THE ENVIRONMENTAL BURDEN OF LIPOPROTEIN APHERESIS IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA
Aug 11, 2026, 17:16 PM -
MAPPING FACILITATOR MECHANISMS TO POLICY BARRIERS TO DRUG REPURPOSING: AN ITERATIVE DEVELOPMENT OF MATCHED PAIR MATRIX
Aug 11, 2026, 17:16 PM -
EARLY ACCESS, UNCERTAIN RETURNS: EAMS AND ITS INFLUENCE ON UK HTA OUTCOMES IN RARE DISEASES
Aug 11, 2026, 17:16 PM
